The Effect of Norcantharidin on Proliferation and Invasiveness of SW579 Cell

Article Preview

Abstract:

To explore the effect of Norcantharidin on the biological behavior of SW579 cells. The method of MTT is used to detect the inhibition of Norcantharidin with different concentration on the proliferation of SW579 cells. Transwll assay detects the inhibition of cantharidin on the invasiveness of SW579 cells. And ELISA assay detects the related invasion protein MMP2. ELISA method is used to detect VEGF expression level, and to study the inhibition of cantharidin on the angiogenesis. MTT results indicate that cantharidin has inhibition effects on the proliferation of SW579 cell, and with the increase of concentration, the inhibition effects are enhanced. Transwll assay and ELISA assay indicates that cantharidin has inhibition effects on the invasiveness of SW579 cell. The results of VEGF suggest that cantharidin has inhibition effects on angiogenesis.

You might also be interested in these eBooks

Info:

Periodical:

Pages:

335-338

Citation:

Online since:

November 2014

Export:

Price:

Permissions CCC:

Permissions PLS:

Сopyright:

© 2014 Trans Tech Publications Ltd. All Rights Reserved

Share:

Citation:

[1] Hegedüs L. N Eng J Med. 2004, 351(17): 1764-1771.

Google Scholar

[2] Kok SH, Cheng SJ, Hong CY, et al. Cancer Lett. Vol. 217(1), (2005), pp.43-52.

Google Scholar

[3] Yu CC, Ko FY, Yu CS, et al. Int J Oncol. Vol. 41(3), (2012), pp.1050-1060.

Google Scholar

[4] Zhang S, Li G, Ma X, et al. Cell Signal. Vol. (2012) , 24(9), pp.1803-1809.

Google Scholar

[5] Fan YZ, Fu JY, Zhao ZM, Chen CQ. World J Gastroenterol. Vol. 11(16), (2005), pp.2431-2437.

Google Scholar

[6] Peng C, Liu X, Liu E, et al. Cancer Sci., Vol. 100 (12), (2009), pp.2302-2308.

Google Scholar

[7] Chen YJ, Chang WM, Liu YW, et al. Chem Biol Interact. Vol. 181(3), (2009), pp.440-446.

Google Scholar

[8] Li JL, Cai YC, Liu XH, Xian LJ. Anticancer Drugs. Vol. 17(3), (2006), pp.307-314.

Google Scholar

[9] Chen YN, Cheng CC, Chen JC, et al. Br J Pharmacol. Vol. 140(3), (2003), pp.461-470.

Google Scholar

[10] Liu Q, Duan H, Luan J, et al. Cytotechnology. Vol. 59(3), (2009), pp.211-217.

Google Scholar

[11] Liu S, Yu H, Kumar SM, et al. Cancer Biol Ther. Vol. 12(11), (2011), pp.1005-1014.

Google Scholar

[12] Yang PY, Chen MF, Kao YH, et al. Toxicol In Vitro. Vol. 25(3), (2011), pp.699-707.

Google Scholar

[13] An WW, Gong XF, Wang MW, et al. Acta Pharmacol Sin. Vol. 25(11), (2004), pp.1502-1508.

Google Scholar

[14] Zhang JT, Fan YZ, Chen CQ, et al. Int J Oncol. Vol. 40(5) , (2012), pp.1501-1514.

Google Scholar

[15] Zhang L, Ji Q, Liu X, et al. Cancer Sci. Vol. 104(5), (2013), pp.604-610.

Google Scholar

[16] Sternlicht MD, Werb Z. Ann Rev Cell Dev Biol. Vol. 17, (2001), pp.463-516.

Google Scholar

[17] Yeh CB, Hsieh MJ, Hsieh YH, et al. PLoS One. Vol. 7(2), (2012), p. e31055.

Google Scholar